论文部分内容阅读
输血前试验是临床避免输血反应的最后一道实验室关口,关乎临床输血的安全、有效[1]。完整的输血前血型相关检测包括血型鉴定、抗体筛查、交叉配血试验等,是临床安全输血的重要保证。我们在对本院住院患者输血前血型鉴定时,发现异基因造血干细胞移植后ABO血型变异1例,报告如下。1病例介绍患者,男,18岁,籍贯甘肃,2003年8月在北京儿童医院确诊为急性淋巴细胞性白血病。2009年在北京德辉医院行
Pre-transfusion tests are clinically the last to avoid transfusion reaction laboratory level, related to the safety of clinical transfusion, effective [1]. Complete blood transfusion related blood tests, including blood type identification, antibody screening, cross matching blood test, is an important guarantee for clinical transfusion safety. In our hospital inpatient blood transfusion before the identification of blood type found in allogeneic hematopoietic stem cell transplantation ABO blood group variation in 1 case, the report is as follows. 1 case description The patient, male, 18 years old, native of Gansu, August 2003 in Beijing Children’s Hospital diagnosed with acute lymphoblastic leukemia. 2009 in Beijing Dehui Hospital